We synthesized a new non-stimulatory MR1 ligand that inhibits MAIT cell activation, and demonstrated that the treatment of mice with the MR1 ligand reduced autoantibody production and the severity of lupus nephritis. Here, MR1 is linked to lupus nephritis.